Trump will hold meeting on vaping

President Trump plans to hold a meeting with officials from the e-cigarette industry and medical field amid an epidemic of vaping-related illnesses and deaths, The Wall Street Journal reported.

Trump previously announced a plan to ban non-tobacco flavored e-cigarette products in September over the epidemic of vaping injuries. As of Nov. 8, more than 2,000 people have been diagnosed with the illness, e-cigarette, or vaping, product use associated lung injury (EVALI), and 39 deaths have been reported.

However, Trump walked back on its planned ban, according to recent November reports. The administration also made an exception for menthol flavors in its plan.

The meeting with officials will include a group of advocacy, industry, non-profits, medical associations and state officials, the WSJ reported. Among the policy considerations is raising the minimum purchasing age from 18 to 21, which is supported by e-cigarette company Juul.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.